These three studies look at neurodegeneration and brain injury from different angles, but they all point to the same larger question: what actually drives neurons and synapses to fail? In stroke-related ischemia and reperfusion injury, one study shows that silencing Gadd45α may protect the brain by reducing FOXO1 signaling, oxidative stress, DNA damage, and neuron death. In dementia with Lewy bodies, another study challenges a long-held assumption by finding that Lewy body burden itself may not explain neuronal or synaptic loss.
The third paper shifts attention to ALS and frontotemporal dementia, showing how mitochondrial oxidative stress may alter TDP-43 behavior through PP1 signaling and disrupt RNA granules at key cellular contact sites. Together, these findings suggest that visible disease markers may not always be the main source of damage, and that deeper stress-response pathways could be critical targets for future research. The broader significance is a more refined view of neurological disease, one that looks beyond obvious pathology and toward the cellular mechanisms that shape injury, resilience, and degeneration.
1. Gadd45α silencing alleviates cerebral ischemia–reperfusion injury by suppressing FOXO1 signaling
Gadd45α silencing reduced brain injury after ischemic stroke by suppressing FOXO1 signaling, lowering oxidative stress, DNA damage, and neuronal apoptosis. It also improved neurological function and supported synaptic activity in preclinical models.
2. Lewy Bodies Are Not Associated With Neuronal or Synaptic Loss in Dementia With Lewy Bodies
Analysis of brain tissue from dementia with Lewy bodies found that Lewy body burden was not linked to neuronal or synaptic loss, challenging the view that these protein aggregates are primary drivers of neurodegeneration. The findings point to other α-synuclein-related mechanisms that may contribute to disease progression.
3. TDP-43 oxidation and PP1 crosstalk at RNA granule-mitochondria contact sites
Researchers identified a cellular pathway linking mitochondrial oxidative stress to TDP-43 behavior, showing how changes in TDP-43 oxidation and PP1 signaling may disrupt RNA granules and contribute to ALS and frontotemporal dementia.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
